Shenzhen Salubris Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd., explained in plain language.
-
New hope for stubborn high blood pressure: experimental drug SAL0140 enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called SAL0140 in people whose high blood pressure remains high despite current treatments. About 252 adults aged 18-75 with uncontrolled hypertension will receive either the drug or a placebo for 12 weeks. The goal is to see if SAL0140 safel…
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New osteoporosis shot aims to strengthen bones in older women
Disease control Recruiting nowThis study tests a new drug called SAL056 in postmenopausal women with osteoporosis. The goal is to find the safest and most effective dose. About 200 women aged 45 to 80 will receive different doses of the drug or a control treatment for around 10 weeks. The study focuses on sid…
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental blood pressure pill gets first safety check in humans
Knowledge-focused Recruiting nowThis study is testing an experimental drug called allisartan isoproxil in 54 healthy Chinese adults. Participants will receive a single dose of either the drug or a placebo to see how the body processes it and whether it causes any side effects. The goal is to gather safety and d…
Phase: PHASE4 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:08 UTC